Additional Information
Book Details
Abstract
The premier drug guide for nurses and midwives since 1983.
Now in its first digital version, Havard's Nursing Guide to Drugs, 10th edition mobile-optimised site brings over 30 years of knowledge to your fingertips, allowing you to search by body system, therapeutic class or drug name. The same trusted, safe and up-to-date drug information is now accessible online via your mobile or tablet, providing the perfect support to your study or clinical practice.
It continues to deliver administration information regarding form, action, use, dose, adverse effects and interactions in compliance with current pharmaceutical guidelines from the Therapeutic Goods Administration and MIMS. Nursing points and cautions highlight best practice in drug administration and expanded focus on Patient teaching and advice ensures quality patient care.
- All drugs listed by therapeutic class and by body system
- Both trade names and generic drug names are provided
- Icons indicate cautions for drugs used during pregnancy and breastfeeding, and drug specific restrictions in sport
- Common abbreviations, units and concentrations
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | cover | ||
| Inside Front Cover | ifc1 | ||
| Havard's Nursing Guide to Drugs | i | ||
| Copyright Page | iv | ||
| Contents by Therapeutic Class | v | ||
| Contents by Body System | vii | ||
| Preface | ix | ||
| Introduction | xi | ||
| The nurse’s role in drug therapy | xi | ||
| Assessing the patient | xi | ||
| Children and the elderly | xiii | ||
| Drugs in sport | xiii | ||
| Pregnancy | xiv | ||
| Breastfeeding | xv | ||
| Renal and liver impairment | xv | ||
| Legal requirements | xv | ||
| Storage | xvi | ||
| Drug orders | xvii | ||
| Legal responsibility | xviii | ||
| Drug incidents (errors) | xviii | ||
| A little pharmacokinetics | xix | ||
| Pharmacokinetics and the older person | xx | ||
| Drug dosage | xx | ||
| Drug half-life | xx | ||
| Therapeutic drug monitoring | xxi | ||
| Why measure drug levels? | xxi | ||
| Drug route | xxi | ||
| Oral administration | xxi | ||
| Parenteral administration | xxii | ||
| Intramuscular | xxii | ||
| Subcutaneous | xxii | ||
| Intravenous | xxii | ||
| Guide for safe administration | xxiv | ||
| Check the order | xxiv | ||
| Check the drug | xxiv | ||
| Check the patient | xxiv | ||
| Documentation | xxv | ||
| Disposal | xxv | ||
| Drug effects | xxv | ||
| Summary | xxvi | ||
| At a glance | xxvi | ||
| Available forms | xxvi | ||
| Action | xxvi | ||
| Use | xxvi | ||
| Dose | xxvi | ||
| Adverse effects | xxvi | ||
| Interactions | xxvii | ||
| Nursing points/Cautions | xxvii | ||
| Patient teaching and advice | xxvii | ||
| General Patient teaching and advice | xxviii | ||
| Dosage | xxx | ||
| How to take | xxx | ||
| Adverse effects | xxxi | ||
| Storage | xxxi | ||
| Other issues | xxxii | ||
| Reviewers | xxxiii | ||
| Acne treatment | 1 | ||
| Retinoids | 2 | ||
| General Actions of retinoids | 2 | ||
| General Adverse effects of oral retinoids | 2 | ||
| General Interactions of oral retinoids | 2 | ||
| General Nursing points/Cautions for retinoids | 2 | ||
| General Patient teaching and advice for retinoids | 3 | ||
| Topical therapy | 3 | ||
| Oral therapy | 4 | ||
| ACITRETIN (Neotigason, Novatin) | 5 | ||
| Analgesics and non-steroidal anti-inflammatory drugs (NSAIDs) | 11 | ||
| General Actions of NSAIDs (not paracetamol) | 11 | ||
| General Adverse effects of NSAIDs (not paracetamol) | 12 | ||
| General Interactions of NSAIDs (not paracetamol) | 12 | ||
| General Nursing points/Cautions for NSAIDs (not paracetamol) | 13 | ||
| General Patient teaching and advice for NSAIDs | 14 | ||
| Topical gel | 14 | ||
| Eye drops | 15 | ||
| Suppositories | 15 | ||
| ASPIRIN (Aspro preparations, Aspro Clear Extra Strength, Astrix 100, Astrix Tablets, Cardasa, Cardiprin 100, Cartia, Disprin preparations, Solprin, Spren) | 16 | ||
| Available forms | 16 | ||
| Action | 16 | ||
| Use | 16 | ||
| Dose | 16 | ||
| Adverse effects | 16 | ||
| Interactions | 16 | ||
| Nursing points/Cautions | 17 | ||
| Anorectics and weight-loss agents | 37 | ||
| LIRAGUTIDE (Saxenda, Victoza) | 37 | ||
| Available form | 37 | ||
| Action | 37 | ||
| Antacids | 41 | ||
| ALUMINIUM HYDROXIDE HYDRATE (ALUMINIUM HYDROXIDE) (Alu-Tab) | 41 | ||
| Available form | 41 | ||
| Action | 41 | ||
| Use | 41 | ||
| Dose | 41 | ||
| Adverse effects | 41 | ||
| Interactions | 41 | ||
| Nursing points/Cautions | 41 | ||
| Anthelmintics | 44 | ||
| General Patient teaching and advice for helminth infestation | 44 | ||
| ALBENDAZOLE (Eskazole, Zentel) | 45 | ||
| Available forms | 45 | ||
| Action | 45 | ||
| Use | 45 | ||
| Dose | 45 | ||
| Hydatid disease | 45 | ||
| Neurocysticercosis | 45 | ||
| Capillariasis | 45 | ||
| Pinworm, threadworm, roundworm, hookworm, whipworm | 45 | ||
| Strongyloides | 45 | ||
| Cutaneous larva migrans | 45 | ||
| Mixed worm infestation (including liver flukes) | 46 | ||
| Tape worm | 46 | ||
| Adverse effects | 46 | ||
| Interactions | 46 | ||
| Nursing points/Cautions | 46 | ||
| Patient teaching and advice | 46 | ||
| IVERMECTIN (Soolantra, Stromectol) | 47 | ||
| Available forms | 47 | ||
| Action | 47 | ||
| Use | 47 | ||
| Dose | 47 | ||
| Adverse effects | 47 | ||
| Strongyloidiasis | 47 | ||
| Onchocerciasis | 47 | ||
| Scabies | 47 | ||
| Rosacea | 47 | ||
| Nursing points/Cautions | 48 | ||
| Patient teaching and advice | 48 | ||
| Scabies | 48 | ||
| Rosacea | 48 | ||
| MEBENDAZOLE (Combantrin-1 with Mebendazole, Combantrin-1 with Mebendazole Chocolate Squares, DeWorm Chewable Tablets, Ridworm, Vermox) | 49 | ||
| Available forms | 49 | ||
| Anti-Alzheimer’s Agents | 52 | ||
| General Actions of anti-Alzheimer’s agents (anticholinesterases) | 52 | ||
| General Adverse effects of anti-Alzheimer’s agents (anticholinesterases) | 52 | ||
| General Interactions of anti-Alzheimer’s agents (anticholinesterases) | 53 | ||
| General Nursing points/Cautions for anti-Alzheimer’s agents (anticholinesterases) | 53 | ||
| General Patient/Carer teaching and advice for anti-Alzheimer’s agents | 53 | ||
| DONEPEZIL HYDROCHLORIDE (Arazil, Aricept, Aridon, Aridon APN, Donepezil RBX, Donepezil-DRLA, Donepezil-GA) | 54 | ||
| Antianginal agents | 58 | ||
| General Patient teaching and advice for antianginal agents | 59 | ||
| GLYCERYL TRINITRATE (often abbreviated to GTN) (known as nitroglycerin in USA) (Anginine, DBL Glyceryl Trinitrate Concentrate Injection, Lycinate, Minitran, Nitrolingual Pump Spray, Nitro-Dur, Transiderm-Nitro) | 59 | ||
| Available forms | 59 | ||
| Action | 59 | ||
| Use | 60 | ||
| Dose | 60 | ||
| Treatment of acute attack | 60 | ||
| Prophylaxis | 60 | ||
| Adverse effects | 60 | ||
| Interactions | 60 | ||
| Nursing points/Cautions | 61 | ||
| Patient teaching and advice | 62 | ||
| Sublingual tablets | 62 | ||
| Sublingual spray | 62 | ||
| Transdermal patch | 63 | ||
| Note | 63 | ||
| ISOSORBIDE DINITRATE | 63 | ||
| ISOSORBIDE MONONITRATE (Duride, Imdur Durules, Isomonit, Isosorbide AN, Isosorbide PS, Monodur Durules) | 63 | ||
| Available forms | 63 | ||
| Action | 63 | ||
| Use | 64 | ||
| Dose | 64 | ||
| Acute angina | 64 | ||
| Prophylactic treatment of angina pectoris, myocardial ischaemia | 64 | ||
| Acute left ventricular failure | 64 | ||
| Chronic left ventricular failure | 64 | ||
| Adverse effects | 64 | ||
| Interactions | 64 | ||
| Nursing points/Cautions | 64 | ||
| Patient teaching and advice | 65 | ||
| IVABRADINE (Coralan) | 65 | ||
| Available forms | 65 | ||
| Action | 65 | ||
| Use | 65 | ||
| Dose | 66 | ||
| Adverse effects | 66 | ||
| Interactions | 66 | ||
| Nursing points/Cautions | 66 | ||
| Patient teaching and advice | 67 | ||
| NICORANDIL (Ikorel, Ikotab) | 67 | ||
| Available forms | 67 | ||
| Action | 67 | ||
| Use | 67 | ||
| Dose | 67 | ||
| Adverse effects | 67 | ||
| Interactions | 67 | ||
| Nursing points/Cautions | 67 | ||
| Patient teaching and advice | 68 | ||
| PERHEXILINE MALEATE (Pexsig) | 68 | ||
| Available form | 68 | ||
| Action | 68 | ||
| Use | 68 | ||
| Dose | 68 | ||
| Adverse effects | 68 | ||
| Short term (within 24 hours) | 68 | ||
| Long term (≥ 12 weeks of continuous therapy) | 68 | ||
| Interactions | 68 | ||
| Nursing points/Cautions | 69 | ||
| Patient teaching and advice | 69 | ||
| Antianxiety agents | 70 | ||
| General Actions of antianxiety agents | 70 | ||
| General Adverse effects of antianxiety agents | 71 | ||
| General Interactions of antianxiety agents | 71 | ||
| General Nursing points/Cautions for antianxiety agents | 71 | ||
| General Patient teaching and advice for antianxiety agents | 72 | ||
| ALPRAZOLAM (Alprax, Kalma) | 73 | ||
| Available forms | 73 | ||
| Action | 73 | ||
| Use | 73 | ||
| Dose | 73 | ||
| Adverse effects | 73 | ||
| Interactions | 73 | ||
| Nursing points and Cautions/Patient teaching and advice | 73 | ||
| BROMAZEPAM (Lexotan) | 74 | ||
| Available forms | 74 | ||
| Antiarrhythmic agents | 78 | ||
| Class I | 78 | ||
| Class IA | 78 | ||
| DISOPYRAMIDE (Rythmodan) | 78 | ||
| Available forms | 78 | ||
| Action | 78 | ||
| Use | 79 | ||
| Dose | 79 | ||
| Adverse effects | 79 | ||
| Interactions | 79 | ||
| Nursing points/Cautions | 79 | ||
| Patient teaching and advice | 80 | ||
| Class IB | 81 | ||
| LIDOCAINE (LIGNOCAINE) HYDROCHLORIDE (Lidocaine Injection, Min-I-Jet Lidocaine Hydrochloride, Xylocard) | 81 | ||
| Available forms | 81 | ||
| Action | 81 | ||
| Use | 81 | ||
| Dose | 81 | ||
| Adverse effects | 81 | ||
| Interactions | 81 | ||
| Nursing points/Cautions | 82 | ||
| Note | 82 | ||
| Class IC | 83 | ||
| FLECAINIDE ACETATE (Flecatab, Tambocor) | 83 | ||
| Available forms | 83 | ||
| Action | 83 | ||
| Use | 83 | ||
| Dose | 83 | ||
| Adverse effects | 83 | ||
| Interactions | 83 | ||
| Nursing points/Cautions | 83 | ||
| Patient teaching and advice | 84 | ||
| Class II | 84 | ||
| Class III | 85 | ||
| AMIODARONE HYDROCHLORIDE (Aratac, Cardinorm, Cordarone X, Rithmik) | 85 | ||
| Available forms | 85 | ||
| Action | 85 | ||
| Use | 85 | ||
| Dose | 85 | ||
| Adverse effects | 85 | ||
| Interactions | 85 | ||
| Nursing points/Cautions | 86 | ||
| Patient teaching and advice | 87 | ||
| SOTALOL HYDROCHLORIDE (Cardol, Cardol 80 mg, Solavert, Sotacor) | 87 | ||
| Available forms | 87 | ||
| Action | 87 | ||
| Use | 87 | ||
| Dose | 87 | ||
| Adverse effects | 88 | ||
| Interactions | 88 | ||
| Nursing points/Cautions | 88 | ||
| Patient teaching and advice | 89 | ||
| Class IV | 89 | ||
| Atypical Antiarrhythmic Agents | 90 | ||
| ADENOSINE (Adenocor, Adenoscan Adenosine Mylan Injection) | 90 | ||
| Available forms | 90 | ||
| Action | 90 | ||
| Use | 90 | ||
| Dose | 90 | ||
| Adverse effects | 90 | ||
| Interactions | 90 | ||
| Nursing points/Cautions | 90 | ||
| Patient teaching and advice | 91 | ||
| Antiasthma agents, bronchodilators and respiratory agents | 92 | ||
| Symptom relievers (bronchodilators) | 93 | ||
| Symptom controllers (bronchodilators) | 93 | ||
| Symptom preventers (prophylactic and anti-inflammatory drugs) | 93 | ||
| General Patient teaching and advice for antiasthma agents and bronchodilators | 93 | ||
| Spacer device | 94 | ||
| Nebuliser | 94 | ||
| Aerolizer | 94 | ||
| Bronchodilators (Beta-2 Adrenoceptor Agonists (also Called Beta-2 Agonists)) | 95 | ||
| General Adverse effects of beta-2 adrenoceptor agonists | 95 | ||
| Common effects | 95 | ||
| Less common | 95 | ||
| General Interactions of beta-2 adrenoceptor agonists | 95 | ||
| FORMOTEROL (EFORMOTEROL) FUMARATE DIHYDRATE (Foradile, Oxis Turbuhaler) | 96 | ||
| Available forms | 96 | ||
| Action | 96 | ||
| Use | 96 | ||
| Dose | 96 | ||
| Adverse effects | 96 | ||
| Interactions | 96 | ||
| Nursing points/Cautions | 96 | ||
| Patient teaching and advice | 97 | ||
| Note | 97 | ||
| INDACATEROL (Onbrez Breezhaler) | 97 | ||
| Available form | 97 | ||
| Action | 97 | ||
| Use | 97 | ||
| Dose | 97 | ||
| Adverse effects | 97 | ||
| Interactions | 97 | ||
| Nursing points/Cautions | 97 | ||
| Patient teaching and advice | 98 | ||
| Note | 98 | ||
| OLODATEROL (Striverdi Respimat) | 98 | ||
| Available form | 98 | ||
| Action | 98 | ||
| Use | 98 | ||
| Dose | 98 | ||
| Adverse effects | 98 | ||
| Interactions | 99 | ||
| Nursing points/Cautions | 99 | ||
| Patient teaching and advice | 99 | ||
| Note | 100 | ||
| SALBUTAMOL SULFATE (known as albuterol in the USA) (Airomir Autohaler and Inhaler, Asmol CFC-free Inhaler, Asmol Uni Dose, Butamol, Epaq, Salbutamol Inhalation Solution, Ventolin preparations, Ventolin Obstetric Injection) | 100 | ||
| Available forms | 100 | ||
| Action | 100 | ||
| Use | 100 | ||
| Dose | 100 | ||
| Adverse effects | 100 | ||
| Interactions | 100 | ||
| Nursing points/Cautions | 101 | ||
| Patient teaching and advice | 101 | ||
| Metered dose aerosol inhaler | 102 | ||
| Rotahaler | 102 | ||
| Autohaler | 103 | ||
| SALMETEROL XINAFOATE (Serevent) | 104 | ||
| Available form | 104 | ||
| Antibacterial agents | 136 | ||
| General Nursing points/Cautions for antibacterial agents | 137 | ||
| General Patient teaching and advice for antibacterial agents | 139 | ||
| Inhibitors of Bacterial Cell Wall Synthesis | 139 | ||
| Penicillins | 140 | ||
| General Actions of penicillins | 140 | ||
| General Uses of penicillins | 140 | ||
| General Adverse effects of penicillins | 140 | ||
| General Interactions of penicillins | 141 | ||
| General Nursing points/Cautions for penicillins | 141 | ||
| General Patient teaching and advice for penicillins | 142 | ||
| AMOXICILLIN SODIUM | 142 | ||
| AMOXICILLIN TRIHYDRATE (Alphamox, Amoxil Oral, Bgramin, Cilamox, Maxamox, Ranmoxy, Xycilan, Yomax) | 142 | ||
| Available forms | 142 | ||
| Action | 143 | ||
| Use | 143 | ||
| Dose | 143 | ||
| Adverse effects | 143 | ||
| Interactions | 143 | ||
| Nursing points/Cautions | 144 | ||
| Patient teaching and advice | 144 | ||
| Note | 144 | ||
| AMOXICILLIN TRIHYDRATE WITH CLAVULANIC ACID (Augmentin preparations, AlphaClav Duo, AlphaClav Duo Forte, AmoxyClav, Clamoxyl preparations, Clavam, Clavulin preparations, Clavycillin, Curam preparations, GA-Amclav, Moxiclav preparations) | 144 | ||
| Available forms | 144 | ||
| Action | 144 | ||
| Use | 144 | ||
| Dose | 144 | ||
| Adverse effects | 145 | ||
| Interactions | 145 | ||
| Nursing points/Cautions | 145 | ||
| Patient teaching and advice | 145 | ||
| AMPICILLIN SODIUM (Ampicyn, Austrapen, Ibimycin) | 145 | ||
| Available forms | 145 | ||
| Action | 145 | ||
| Use | 145 | ||
| Dose | 145 | ||
| Anticoagulants and antithrombotic agents | 216 | ||
| General Patient teaching and advice for anticoagulants | 217 | ||
| Heparin and Low Molecular Weight Heparins (LMWHs) | 217 | ||
| HEPARIN SODIUM (Heparin Injection BP, Heparin Sodium Injection, Heparinised Saline) | 217 | ||
| Available forms | 217 | ||
| Action | 217 | ||
| Use | 218 | ||
| Dose | 218 | ||
| Adverse effects | 218 | ||
| Interactions | 218 | ||
| Nursing points/Cautions | 219 | ||
| Subcutaneous injection technique | 219 | ||
| General | 219 | ||
| Patient teaching and advice | 220 | ||
| Note | 220 | ||
| Low Molecular Weight Heparins | 221 | ||
| DALTEPARIN SODIUM (Fragmin) | 221 | ||
| Available forms | 221 | ||
| Action | 221 | ||
| Use | 221 | ||
| Dose | 221 | ||
| Acute DVT treatment | 221 | ||
| Treatment of symptomatic VTE in those with solid tumour cancers | 221 | ||
| Anticoagulation for haemodialysis | 221 | ||
| Thromboprophylaxis (surgery) | 221 | ||
| Thromboprophylaxis (general surgery associated with high thrombosis risk) | 221 | ||
| Thromboprophylaxis (orthopaedic surgery e.g. hip replacement) | 221 | ||
| Unstable coronary disease | 221 | ||
| Adverse effects | 222 | ||
| Interactions | 222 | ||
| Nursing points/Cautions | 222 | ||
| Patient teaching and advice | 222 | ||
| DANAPAROID SODIUM (Orgaran) | 223 | ||
| Antidepressants | 240 | ||
| General Nursing points/Cautions for all antidepressants | 241 | ||
| General Patient teaching and advice for all antidepressants | 241 | ||
| Tricyclic and Related Antidepressants (TCAs) | 242 | ||
| General Actions of TCAs | 242 | ||
| General Adverse effects of TCAs | 242 | ||
| General Interactions of TCAs | 243 | ||
| General Nursing points/Cautions for TCAs | 244 | ||
| General Patient teaching and advice for TCAs | 244 | ||
| AMITRIPTYLINE HYDROCHLORIDE (Endep, Entrip) | 245 | ||
| Available forms | 245 | ||
| Action | 245 | ||
| Use | 245 | ||
| Dose | 245 | ||
| Depression | 245 | ||
| Enuresis | 245 | ||
| Antidiabetic agents | 267 | ||
| Insulins | 268 | ||
| Available forms | 269 | ||
| General Actions of insulins | 269 | ||
| General Use of insulins | 269 | ||
| Dose | 269 | ||
| General Adverse effects of insulins | 269 | ||
| General Interactions of insulins | 270 | ||
| General Nursing points/Cautions for insulins | 270 | ||
| Short-acting (soluble) insulin | 271 | ||
| Long-acting (depot) insulin | 271 | ||
| Storage | 271 | ||
| Preparation | 271 | ||
| Administration | 272 | ||
| General Patient teaching and advice for insulins | 272 | ||
| Oral Hypoglycaemic Agents | 276 | ||
| General Nursing points/Cautions for oral hypoglycaemic agents | 276 | ||
| General Patient teaching and advice for oral hypoglycaemic agents | 277 | ||
| Sulfonylureas | 278 | ||
| General Actions of sulfonylureas | 278 | ||
| General Uses of sulfonylureas | 278 | ||
| General Adverse effects of sulfonylureas | 278 | ||
| General Interactions of sulfonylureas | 278 | ||
| General Nursing points/Cautions for sulfonylureas | 279 | ||
| General Patient teaching and advice for sulfonylureas | 279 | ||
| GLIBENCLAMIDE (Daonil, Glimel) | 280 | ||
| Available form | 280 | ||
| Action/Use | 280 | ||
| Dose | 280 | ||
| Interactions | 280 | ||
| Adverse effects/Nursing points/Cautions/Patient teaching and advice | 280 | ||
| Note | 280 | ||
| GLICLAZIDE (Diamicron 60 mg MR, Glyade, Glyade MR, Nidem, Oziclide MR) | 280 | ||
| Available forms | 280 | ||
| Antidiarrhoeal agents | 299 | ||
| General Nursing points/Cautions for antidiarrhoeal agents | 300 | ||
| General Patient teaching and advice for antidiarrhoeal agents | 300 | ||
| DIPHENOXYLATE HYDROCHLORIDE | 300 | ||
| Available forms | 300 | ||
| Action | 300 | ||
| Use | 300 | ||
| Dose | 300 | ||
| Adverse effects | 300 | ||
| Interactions | 301 | ||
| Nursing points/Cautions | 301 | ||
| Patient teaching and advice | 301 | ||
| Note | 301 | ||
| LOPERAMIDE HYDROCHLORIDE (Diacare, Diareze, Gastrex, GastroStop, Harmonise, Imodium, Lopedium, Pharmacy Action Diarrhoea Relief, StopIt) | 301 | ||
| Available forms | 301 | ||
| Action | 301 | ||
| Use | 301 | ||
| Dose | 302 | ||
| Adverse effects | 302 | ||
| Interactions | 302 | ||
| Nursing points/Cautions | 302 | ||
| Patient teaching and advice | 302 | ||
| Antidotes, antagonists and chelating agents | 303 | ||
| ACETYLCYSTEINE (Acetadote Concentrated Injection, DBL Acetylcysteine Injection Concentrate) | 303 | ||
| Available forms | 303 | ||
| Action | 303 | ||
| Use | 303 | ||
| Dose | 303 | ||
| Adverse effects | 303 | ||
| Interactions | 303 | ||
| Nursing points/Cautions | 304 | ||
| BETAINE (Cystadane) | 304 | ||
| Available form | 304 | ||
| Action | 304 | ||
| Antiemetic agents | 333 | ||
| Note | 333 | ||
| 5HT3 Receptor Antagonists | 334 | ||
| General Adverse effects of 5HT3 receptor antagonists | 334 | ||
| General Interactions of 5HT3 receptor antagonists | 334 | ||
| General Nursing points/Cautions for 5HT3 receptor antagonists | 334 | ||
| General Patient teaching and advice for 5HT3 receptor antagonists | 334 | ||
| DOLASETRON MESILATE (MESYLATE) MONOHYDRATE (Dolasetron Mesylate) (Anzemet) | 334 | ||
| Available forms | 334 | ||
| Action | 334 | ||
| Use | 334 | ||
| Antiepileptics | 347 | ||
| General Adverse effects of antiepileptics | 348 | ||
| General Nursing points/Cautions for antiepileptics | 348 | ||
| General Patient teaching and advice for antiepileptics | 349 | ||
| ACETAZOLAMIDE (Diamox, Glaumox, Powder for Injection) | 350 | ||
| Available forms | 350 | ||
| Action | 350 | ||
| Antifungal agents | 378 | ||
| AMOROLFINE (Aporyl, Loceryl, Myconail, Sandoz Nail Repair) | 378 | ||
| Available form | 378 | ||
| Action | 378 | ||
| Use | 378 | ||
| Antiglaucoma agents | 408 | ||
| General Actions of antiglaucoma agents | 408 | ||
| General Ocular Adverse effects of antiglaucoma agents | 409 | ||
| General Adverse effects (uncommon) of antiglaucoma agents | 409 | ||
| General Nursing points/Cautions for antiglaucoma agents | 409 | ||
| General Patient teaching and advice for antiglaucoma agents | 409 | ||
| Instillation of eye drops | 410 | ||
| ACETAZOLAMIDE (Diamox, Glaumox Powder for Injection) | 410 | ||
| Available forms | 410 | ||
| Action | 410 | ||
| Antigout and uricolytic agents | 422 | ||
| ALLOPURINOL (Allosig, Progout, Zyloprim) | 422 | ||
| Available forms | 422 | ||
| Action | 422 | ||
| Use | 423 | ||
| Dose | 423 | ||
| Gout | 423 | ||
| High urate turnover conditions | 423 | ||
| High urate turnover conditions (with renal impairment) | 423 | ||
| Adverse effects | 423 | ||
| Interactions | 423 | ||
| Nursing points/Cautions | 423 | ||
| Patient teaching and advice | 424 | ||
| COLCHICINE (Colgout, Lengout) | 424 | ||
| Available form | 424 | ||
| Action | 424 | ||
| Use | 424 | ||
| Dose | 424 | ||
| Adverse effects | 424 | ||
| Interactions | 425 | ||
| Nursing points/Cautions | 425 | ||
| Patient teaching and advice | 426 | ||
| FEBUXOSTAT (Adenuric) | 426 | ||
| Available form | 426 | ||
| Action | 426 | ||
| Use | 426 | ||
| Dose | 426 | ||
| Adverse effects | 426 | ||
| Interactions | 426 | ||
| Nursing points/Cautions | 426 | ||
| Patient teaching and advice | 427 | ||
| PROBENECID (Pro-Cid) | 427 | ||
| Available form | 427 | ||
| Action | 427 | ||
| Use | 427 | ||
| Dose | 427 | ||
| Adverse effects | 427 | ||
| Interactions | 428 | ||
| Nursing points/Cautions | 428 | ||
| Patient teaching and advice | 428 | ||
| RASBURICASE RYS (Fasturtec) | 429 | ||
| Available forms | 429 | ||
| Action | 429 | ||
| Use | 429 | ||
| Dose | 429 | ||
| Adverse effects | 429 | ||
| Nursing points/Cautions | 429 | ||
| Antihistamines | 431 | ||
| General Actions of antihistamines | 432 | ||
| General Adverse effects of antihistamines | 432 | ||
| General Interactions of antihistamines | 432 | ||
| General Nursing points/Cautions for antihistamines | 432 | ||
| General Patient teaching and advice for antihistamines | 432 | ||
| Nasal spray instillation | 432 | ||
| Eye drop instillation | 433 | ||
| ALIMEMAZINE (TRIMEPRAZINE) TARTRATE (Vallergan, Vallergan Syrup Forte) | 433 | ||
| Available forms | 433 | ||
| Action | 433 | ||
| Use | 434 | ||
| Dose | 434 | ||
| Adverse effects | 434 | ||
| Interactions | 434 | ||
| Nursing points/Cautions | 434 | ||
| Antihypertensive agents | 446 | ||
| General Patient teaching and advice for antihypertensive agents | 447 | ||
| Alpha-Adrenoceptor Blocking Agents | 447 | ||
| General Actions of alpha-adrenoceptor blocking agents | 447 | ||
| General Adverse effects of alpha-adrenoceptor blocking agents | 447 | ||
| General Nursing points/Cautions for alpha-adrenoceptor blocking agents | 448 | ||
| General Patient teaching and advice for alpha-adrenoceptor blocking agents | 448 | ||
| PHENOXYBENZAMINE HYDROCHLORIDE (Dibenyline, Dibenzyline) | 448 | ||
| Available form | 448 | ||
| Action | 448 | ||
| Antimalarial agents | 495 | ||
| The malarial life cycle | 495 | ||
| Treatment | 496 | ||
| Prevention | 496 | ||
| General Patient teaching and advice for people travelling in malarial areas | 496 | ||
| Malaria and pregnancy | 497 | ||
| ARTEMETHER AND LUMEFANTRINE (Riamet) | 497 | ||
| Available forms | 497 | ||
| Action | 497 | ||
| Use | 497 | ||
| Dose | 497 | ||
| Adverse effects | 498 | ||
| Interactions | 498 | ||
| Nursing points/Cautions | 498 | ||
| Patient teaching and advice | 498 | ||
| ATOVAQUONE AND PROGUANIL HYDROCHLORIDE (Malarone Tablets (250/100), Malarone Junior Tablets (62.5/25), Promozio 250/100) | 499 | ||
| Available forms | 499 | ||
| Action | 499 | ||
| Use | 499 | ||
| Dose | 499 | ||
| Prophylaxis | 499 | ||
| Treatment | 499 | ||
| Adverse effects | 499 | ||
| Interactions | 500 | ||
| Nursing points/Cautions | 500 | ||
| Patient teaching and advice | 500 | ||
| MEFLOQUINE HYDROCHLORIDE (Lariam) | 500 | ||
| Available form | 500 | ||
| Action | 500 | ||
| Use | 500 | ||
| Dose (adults and children more than 45 kg) | 501 | ||
| Treatment (non-immune person from endemic malarial area) | 501 | ||
| Treatment (semi-immune person living in malaria endemic area) | 501 | ||
| Malaria prophylaxis (for a stay of 1–3 weeks in a malarial area) | 501 | ||
| Adverse effects | 501 | ||
| Interactions | 501 | ||
| Nursing points/Cautions | 501 | ||
| Patient teaching and advice | 501 | ||
| PRIMAQUINE PHOSPHATE (Primacin) | 502 | ||
| Available form | 502 | ||
| Action | 502 | ||
| Use | 502 | ||
| Dose | 502 | ||
| Adverse effects | 502 | ||
| Interactions | 502 | ||
| Nursing points/Cautions | 502 | ||
| Patient teaching and advice | 503 | ||
| QUININE BISULFATE HEPTAHYDRATE (QUININE BISULFATE) | 503 | ||
| QUININE DIHYDROCHLORIDE | 503 | ||
| QUININE SULFATE DIHYDRATE (QUININE SULFATE) (Quinate) | 503 | ||
| Available forms | 503 | ||
| Action | 503 | ||
| Use | 503 | ||
| Dose | 503 | ||
| Adverse effects | 503 | ||
| Interactions | 504 | ||
| Nursing points/Cautions | 504 | ||
| Patient teaching and advice | 505 | ||
| Note | 505 | ||
| Antimigraine agents | 506 | ||
| CYPROHEPTADINE HYDROCHLORIDE SESQUIHYDRATE (CYPROHEPTADINE HYDROCHLORIDE) (Periactin) | 507 | ||
| Available form | 507 | ||
| Antimycobacterial agents | 515 | ||
| DAPSONE | 516 | ||
| Available forms | 516 | ||
| Action | 516 | ||
| Use | 516 | ||
| Dose | 516 | ||
| Adverse effects | 517 | ||
| Interactions | 517 | ||
| Nursing points/Cautions | 517 | ||
| Patient teaching and advice | 517 | ||
| ETHAMBUTOL HYDROCHLORIDE (Myambutol) | 518 | ||
| Available forms | 518 | ||
| Antineoplastic agents | 527 | ||
| General Adverse effects of antineoplastic agents | 528 | ||
| General Interactions of antineoplastic agents | 528 | ||
| General Nursing points/Cautions for antineoplastic agents | 528 | ||
| General Patient teaching and advice for antineoplastic agents | 530 | ||
| ABIRATERONE ACETATE (Zytiga) | 531 | ||
| Available form | 531 | ||
| Action | 531 | ||
| Use | 531 | ||
| Dose | 531 | ||
| Adverse effects | 531 | ||
| Interactions | 531 | ||
| Nursing points/Cautions | 531 | ||
| Antineoplastic support agents | 642 | ||
| AMIFOSTINE (Ethyol) | 642 | ||
| Available form | 642 | ||
| Action | 642 | ||
| Use | 642 | ||
| Dose | 642 | ||
| Adverse effects | 642 | ||
| Interactions | 642 | ||
| Nursing points/Cautions | 642 | ||
| Patient teaching and advice | 643 | ||
| ANCESTIM (Stemgen) | 643 | ||
| Available form | 643 | ||
| Action | 643 | ||
| Use | 643 | ||
| Dose | 643 | ||
| Adverse effects | 643 | ||
| Nursing points/Cautions | 644 | ||
| Patient teaching and advice | 644 | ||
| MESNA (Uromitexan) | 644 | ||
| Available forms | 644 | ||
| Action | 644 | ||
| Use | 644 | ||
| Dose | 644 | ||
| Adverse effects | 645 | ||
| Interactions | 645 | ||
| Nursing points/Cautions | 645 | ||
| Patient teaching and advice | 645 | ||
| PALIFERMIN (Kepivance) | 645 | ||
| Available form | 645 | ||
| Action | 645 | ||
| Use | 645 | ||
| Anti-parkinson’s agents | 655 | ||
| Anticholinergic Anti-Parkinson’s Agents | 656 | ||
| General Actions of anticholinergic anti-Parkinson’s agents | 656 | ||
| General Uses of anticholinergic anti-Parkinson’s agents | 656 | ||
| General Adverse effects of anticholinergic anti-Parkinson’s agents | 656 | ||
| General Interactions of anticholinergic anti-Parkinson’s agents | 656 | ||
| General Nursing points/Cautions for anticholinergic anti-Parkinson’s agents | 657 | ||
| General Patient teaching and advice for anticholinergic anti-Parkinson’s agents | 657 | ||
| BENZTROPINE MESILATE (BENZTROPINE MESYLATE) (Benztrop, Cogentin) | 658 | ||
| Antiplatelet Agents | 678 | ||
| ABCIXIMAB RMC (ReoPro) | 678 | ||
| Available form | 678 | ||
| Action | 678 | ||
| Use | 678 | ||
| Dose | 678 | ||
| Adverse effects | 679 | ||
| Interactions | 679 | ||
| Nursing points/Cautions | 679 | ||
| ASPIRIN (Aspro preparations, Aspro Clear Extra Strength, Astrix 100, Astrix Tablets, Cardasa, Cardiprin 100, Cartia, Disprin preparations, Solprin, Spren) | 680 | ||
| Antiprotozoal agents | 692 | ||
| ATOVAQUONE (Wellvone Suspension) | 692 | ||
| Available form | 692 | ||
| Action | 692 | ||
| Use | 692 | ||
| Dose | 692 | ||
| Adverse effects | 692 | ||
| Interactions | 693 | ||
| Nursing points/Cautions | 693 | ||
| Patient teaching and advice | 693 | ||
| Note | 693 | ||
| METRONIDAZOLE (Flagyl, Flagyl S Suspension, Metrogyl, Metronidazole Intravenous Infusion, Metronide, Rozex Cream and Gel, Zidoval Vaginal Gel) | 693 | ||
| Available forms | 693 | ||
| Action | 693 | ||
| Use | 693 | ||
| Dose | 694 | ||
| Adverse effects | 694 | ||
| Interactions | 694 | ||
| Nursing points/Cautions | 695 | ||
| Patient teaching and advice | 695 | ||
| PENTAMIDINE ISETIONATE (PENTAMIDINE ISETHIONATE) (DBL Pentamidine Isethionate for Injection) | 696 | ||
| Available form | 696 | ||
| Action | 696 | ||
| Use | 696 | ||
| Dose | 696 | ||
| Adverse effects | 696 | ||
| Interactions | 697 | ||
| Nursing points/Cautions | 697 | ||
| Patient teaching and advice | 697 | ||
| PYRIMETHAMINE (Daraprim) | 697 | ||
| Available form | 697 | ||
| Action | 697 | ||
| Use | 697 | ||
| Dose | 698 | ||
| Adverse effects | 698 | ||
| Interactions | 698 | ||
| Nursing points/Cautions | 698 | ||
| Patient teaching and advice | 698 | ||
| TINIDAZOLE (Fasigyn, Simplotan) | 698 | ||
| Available form | 698 | ||
| Action | 698 | ||
| Use | 698 | ||
| Dose | 699 | ||
| Adverse effects | 699 | ||
| Interactions | 699 | ||
| Nursing points/Cautions | 699 | ||
| Patient teaching and advice | 699 | ||
| Antipsychotic and mood-stabilising agents | 701 | ||
| General Adverse effects of antipsychotics | 702 | ||
| General Interactions of antipsychotics | 703 | ||
| General Nursing points/Cautions for antipsychotics | 704 | ||
| General Patient teaching and advice for antipsychotics | 705 | ||
| AMISULPRIDE (Amipride, Solian, Sulprix) | 706 | ||
| Available forms | 706 | ||
| Action | 706 | ||
| Use | 706 | ||
| Dose | 706 | ||
| Adverse effects | 706 | ||
| Interactions | 706 | ||
| Nursing points/Cautions | 706 | ||
| Patient teaching and advice | 706 | ||
| ARIPIPRAZOLE (Abilify, Ablify Maintena) | 707 | ||
| Available forms | 707 | ||
| Action | 707 | ||
| Use | 707 | ||
| Dose | 707 | ||
| Adverse effects | 707 | ||
| Interactions | 707 | ||
| Nursing points/Cautions | 707 | ||
| Antiulcer agents | 733 | ||
| Histamine H2-Receptor Antagonists | 734 | ||
| General Actions of H2-receptor antagonists | 734 | ||
| General Uses of H2-receptor antagonists | 734 | ||
| General Nursing points/Cautions for H2-receptor antagonists | 734 | ||
| General Patient teaching and advice for H2-receptor antagonists | 734 | ||
| CIMETIDINE (Magicul, Tagamet) | 735 | ||
| Available forms | 735 | ||
| Action | 735 | ||
| Use | 735 | ||
| Dose | 735 | ||
| Adverse effects | 735 | ||
| Interactions | 735 | ||
| Nursing points/Cautions | 735 | ||
| Patient teaching and advice | 735 | ||
| FAMOTIDINE (Ausfam, Famohexal, Pamacid, Pepzan) | 736 | ||
| Antiviral agents | 748 | ||
| General Adverse effects of antiretroviral agents | 748 | ||
| General Interactions of antiretroviral agents | 749 | ||
| General Nursing points/Cautions for antiretroviral agents | 749 | ||
| General Patient teaching and advice for antiretroviral agents | 750 | ||
| Note | 751 | ||
| ABACAVIR (Ziagen) | 751 | ||
| Available forms | 751 | ||
| Action | 751 | ||
| Use | 751 | ||
| Dose | 751 | ||
| Adverse effects | 751 | ||
| Nursing points/Cautions | 751 | ||
| Patient teaching and advice | 751 | ||
| Note | 752 | ||
| ACICLOVIR (Aciclovir Intravenous Infusion, AciVision, Acivir Cold Sore Cream, Acyclo-V, Blistex Antiviral Cold Sore Cream, Lovir, Lovir Cold Sore Cream, Nyal Antiviral Cold Sore Cream, Ozvir, Zovirax Cold Sore Cream, Zovirax Ophthalmic Ointment, Zovirax Tablets) | 752 | ||
| Available forms | 752 | ||
| Action | 752 | ||
| Use | 752 | ||
| Dose | 752 | ||
| Genital herpes | 752 | ||
| Herpes zoster (shingles) | 752 | ||
| Herpes simplex infections | 752 | ||
| Herpes simplex encephalitis (immunocompetent or immunocompromised) | 752 | ||
| Advanced symptomatic HIV disease | 752 | ||
| Adverse effects | 753 | ||
| Interactions | 753 | ||
| Nursing points/Cautions | 753 | ||
| Patient teaching and advice | 753 | ||
| ADEFOVIR DIPIVOXIL (Hepsera) | 754 | ||
| Available form | 754 | ||
| Action | 754 | ||
| Use | 754 | ||
| Dose | 754 | ||
| Adverse effects | 754 | ||
| Interactions | 754 | ||
| Nursing points/Cautions | 754 | ||
| Patient teaching and advice | 755 | ||
| ASUNAPEVIR (Sunvepra) | 755 | ||
| Available form | 755 | ||
| Action | 755 | ||
| Use | 755 | ||
| Dose | 755 | ||
| Adverse effects | 755 | ||
| Interactions | 755 | ||
| Nursing Points/Cautions | 755 | ||
| Patient teaching and advice | 756 | ||
| ATAZANAVIR (Reyataz) | 756 | ||
| Available forms | 756 | ||
| Action | 756 | ||
| Use | 756 | ||
| Dose | 756 | ||
| Therapy naive patient | 756 | ||
| Therapy experienced patient | 756 | ||
| Adverse effects | 756 | ||
| Interactions | 756 | ||
| Nursing points/Cautions | 757 | ||
| Patient teaching and advice | 757 | ||
| Note | 757 | ||
| BOCEPREVIR (Victrelis) | 757 | ||
| Available form | 757 | ||
| Action | 758 | ||
| Use | 758 | ||
| Dose | 758 | ||
| Adverse effects | 758 | ||
| Interactions | 758 | ||
| Nursing points/Cautions | 758 | ||
| Patient teaching and advice | 759 | ||
| CIDOFOVIR (Vistide) | 759 | ||
| Available form | 759 | ||
| Action | 759 | ||
| Use | 759 | ||
| Dose | 759 | ||
| Adverse effects | 759 | ||
| Interactions | 760 | ||
| Nursing points/Cautions | 760 | ||
| Patient teaching and advice | 760 | ||
| DACLATASVIR (Daklinza) | 760 | ||
| Available forms | 760 | ||
| Action | 760 | ||
| Use | 761 | ||
| Dose | 761 | ||
| Adverse effects | 761 | ||
| Interactions | 761 | ||
| Nursing points/Cautions | 761 | ||
| Patient teaching and advice | 761 | ||
| DARUNAVIR (Prezista) | 761 | ||
| Available forms | 761 | ||
| Action | 762 | ||
| Use | 762 | ||
| Dose | 762 | ||
| Adverse effects | 762 | ||
| Interactions | 762 | ||
| Nursing points/Cautions | 762 | ||
| Patient teaching and advice | 762 | ||
| DIDANOSINE (Videx EC) | 763 | ||
| Available forms | 763 | ||
| Action | 763 | ||
| Use | 763 | ||
| Dose | 763 | ||
| Adverse effects | 763 | ||
| Interactions | 763 | ||
| Nursing points/Cautions | 763 | ||
| Bladder function disorder agents | 799 | ||
| ALFUZOSIN HYDROCHLORIDE (Xatral SR) | 800 | ||
| Available form | 800 | ||
| Action | 800 | ||
| Use | 800 | ||
| Dose | 800 | ||
| Adverse effects | 800 | ||
| Interactions | 800 | ||
| Nursing points/Cautions | 800 | ||
| Patient teaching and advice | 800 | ||
| BETHANECHOL CHLORIDE (Urocarb) | 801 | ||
| Available form | 801 | ||
| Bone and calcium regulating agents | 811 | ||
| Bisphosphonates | 812 | ||
| General Actions of bisphosphonates | 812 | ||
| General Uses of bisphosphonates | 812 | ||
| General Adverse effects of bisphosphonates | 813 | ||
| General Interactions of bisphosphonates | 813 | ||
| General Nursing points/Cautions for bisphosphonates | 813 | ||
| General Patient teaching and advice for bisphosphonates | 814 | ||
| ALENDRONIC ACID (ALENDRONATE SODIUM) (Adronat, Alendro, Alendrobell, Densate, Fonat, Fosamax, Fosamax Once Weekly, Ossmax) | 815 | ||
| Cardiac glycosides | 831 | ||
| DIGOXIN (Lanoxin, Sigmaxin) | 831 | ||
| Available forms | 831 | ||
| Action | 831 | ||
| Use | 831 | ||
| Dose | 831 | ||
| Digitalising loading dose | 831 | ||
| Maintenance dose | 832 | ||
| Adverse effects | 832 | ||
| Interactions | 832 | ||
| Nursing points/Cautions | 833 | ||
| Patient teaching and advice | 834 | ||
| Note | 835 | ||
| MILRINONE LACTATE (Milrinone GH Concentrate for Infusion, Primacor Injection) | 835 | ||
| Available form | 835 | ||
| Action | 835 | ||
| Use | 835 | ||
| Dose | 835 | ||
| Adverse effects | 835 | ||
| Nursing points/Cautions | 835 | ||
| Cholinergic and anticholinergic agents | 836 | ||
| Cholinergic (Parasympathomimetic) Agents | 836 | ||
| General Actions of cholinergic agents | 836 | ||
| General Adverse effects of cholinergic agents | 836 | ||
| NEOSTIGMINE METHYLSULFATE (Neostigmine Injection BP) | 837 | ||
| Available forms | 837 | ||
| Action | 837 | ||
| Use | 837 | ||
| Dose | 837 | ||
| Adverse effects | 837 | ||
| Interactions | 837 | ||
| Nursing points/Cautions | 837 | ||
| PYRIDOSTIGMINE BROMIDE (Mestinon) | 838 | ||
| Available forms | 838 | ||
| Action | 838 | ||
| Use | 838 | ||
| Dose | 838 | ||
| Adverse effects | 838 | ||
| Interactions | 838 | ||
| Nursing points/Cautions | 838 | ||
| Patient teaching and advice | 839 | ||
| Anticholinergic Agents | 839 | ||
| General Actions of anticholinergic agents | 839 | ||
| General Adverse effects of anticholinergics | 839 | ||
| General Interactions of anticholinergics | 840 | ||
| General Nursing points/Cautions for anticholinergics | 840 | ||
| General Patient teaching and advice for anticholinergics | 841 | ||
| ATROPINE SULFATE MONOHYDRATE (ATROPINE SULFATE) (Atropine Injection, Atropine Sulfate Injection BP, Atropt, Minims Atropine Eye Drops) | 841 | ||
| Available forms | 841 | ||
| Action | 841 | ||
| Use | 841 | ||
| Dose | 841 | ||
| Corticosteroids | 845 | ||
| General Actions of coticosteroids | 845 | ||
| General Uses of coticosteroids | 846 | ||
| General Adverse effects of coticosteroids | 846 | ||
| General Interactions of coticosteroids | 847 | ||
| General Nursing points/Cautions for coticosteroids | 848 | ||
| Topical | 850 | ||
| Ophthalmic | 851 | ||
| Withdrawal | 851 | ||
| General Patient teaching and advice for coticosteroids | 852 | ||
| Topical (cream, ointment, lotion) | 852 | ||
| Nasal spray instillation | 853 | ||
| Eye drop instillation | 853 | ||
| BETAMETHASONE ACETATE, SODIUM PHOSPHATE | 854 | ||
| BETAMETHASONE DIPROPRONATE | 854 | ||
| BETAMETHASONE VALERATE (Antroquoril, Betnovate preparations, Celestone M Cream and Ointment, Cortival) | 854 | ||
| Available forms | 854 | ||
| Action | 854 | ||
| Use | 854 | ||
| Dose | 854 | ||
| Parenteral (1 mL = 5.7 mg beclomethasone) | 854 | ||
| Topical | 854 | ||
| Adverse effects | 855 | ||
| Interactions | 855 | ||
| Nursing points/Cautions/Withdrawal | 855 | ||
| Patient teaching and advice | 855 | ||
| Note | 855 | ||
| BUDESONIDE (Budamax, Budenofalk, Budenofalk Foam Enema, Cortiment, Entocort, Pulmicort, Rhinocort, Rhinocort Hayfever) | 855 | ||
| Available forms | 855 | ||
| Cough suppressants, expectorants and mucolytics | 869 | ||
| AMMONIUM CHLORIDE (Nyal Bronchitis Cough Medicine) | 869 | ||
| Available form | 869 | ||
| Action | 869 | ||
| Use | 869 | ||
| Dose | 869 | ||
| Nursing points/Cautions | 869 | ||
| Patient teaching and advice | 869 | ||
| Dermatological agents | 876 | ||
| Topical Ectoparasitical Agents | 876 | ||
| Pediculosis (Lice Infestation) | 876 | ||
| General Patient Teaching and Advice for pediculicides | 876 | ||
| BENZYL ALCOHOL (NeutraLice Advance) | 877 | ||
| Disease-modifying antirheumatic drugs (DMARDs) | 889 | ||
| Conventional Dmards | 890 | ||
| AURANOFIN (Ridaura) | 890 | ||
| Available form | 890 | ||
| Action | 890 | ||
| Use | 890 | ||
| Dose | 890 | ||
| Adverse effects | 890 | ||
| Interactions | 890 | ||
| Nursing points/Cautions | 890 | ||
| Patient teaching and advice | 891 | ||
| CICLOSPORIN (CYCLOSPORIN) (Neoral, Sandimmun) | 891 | ||
| Available forms | 891 | ||
| Action | 891 | ||
| Use | 891 | ||
| Dose | 891 | ||
| Adverse effects | 892 | ||
| Interactions | 892 | ||
| Nursing points/Cautions | 893 | ||
| Patient teaching and advice | 894 | ||
| HYDROXYCHLOROQUINE SULFATE (Hequinel, Plaquenil) | 895 | ||
| Available form | 895 | ||
| Action | 895 | ||
| Use | 895 | ||
| Dose | 895 | ||
| Adverse effects | 895 | ||
| Interactions | 896 | ||
| Nursing points/Cautions | 896 | ||
| Patient teaching and advice | 896 | ||
| LEFLUNOMIDE (Arabloc, Arava, Lunava) | 897 | ||
| Available forms | 897 | ||
| Action | 897 | ||
| Use | 897 | ||
| Dose | 897 | ||
| Adverse effects | 897 | ||
| Interactions | 897 | ||
| Nursing points/Cautions | 898 | ||
| Patient teaching and advice | 898 | ||
| METHOTREXATE (Methaccord, Methoblastin, Methotrexate Injection and Tablets, Trexject) | 899 | ||
| Available forms | 899 | ||
| Action | 899 | ||
| Use | 899 | ||
| Dose | 899 | ||
| Adverse effects | 899 | ||
| Interactions | 900 | ||
| Nursing points/Cautions | 900 | ||
| Patient teaching and advice | 901 | ||
| PENICILLAMINE (D Penamine) | 902 | ||
| Available forms | 902 | ||
| Action | 902 | ||
| Use | 902 | ||
| Dose | 902 | ||
| Adverse effects | 902 | ||
| Interactions | 903 | ||
| Nursing points/Cautions | 903 | ||
| Patient teaching and advice | 903 | ||
| SODIUM AUROTHIOMALATE (Gold Salt) (Myocrisin) | 904 | ||
| Available forms | 904 | ||
| Action | 904 | ||
| Use | 904 | ||
| Dose | 904 | ||
| Rheumatoid arthritis | 904 | ||
| Still’s disease | 904 | ||
| Adverse effects | 904 | ||
| Interactions | 904 | ||
| Nursing points/Cautions | 904 | ||
| Patient teaching and advice | 905 | ||
| SULFASALAZINE (Pyralin EN, Salazopyrin, Salazopyrin EN-Tabs) | 905 | ||
| Available forms | 905 | ||
| Action | 905 | ||
| Use | 905 | ||
| Dose | 905 | ||
| Adverse effects | 905 | ||
| Interactions | 906 | ||
| Nursing points/Cautions | 906 | ||
| Patient teaching and advice | 906 | ||
| Tumour Necrosis Factor Alpha (TNF-α) Antagonists | 907 | ||
| General Actions of TNF-α antagonists | 907 | ||
| General Adverse effects of TNF-α antagonists | 907 | ||
| General Interactions of TNF-α antagonists | 907 | ||
| General Nursing points/Cautions for TNF-α antagonists | 907 | ||
| General Patient teaching and advice for TNF-α antagonists | 908 | ||
| ADALIMUMAB (Humira) | 909 | ||
| Available forms | 909 | ||
| Action | 909 | ||
| Use | 909 | ||
| Dose | 910 | ||
| Adverse effects | 910 | ||
| Interactions | 910 | ||
| Nursing points/Cautions | 910 | ||
| Patient teaching and advice | 910 | ||
| CERTOLIZUMAB PEGOL (Cimzia) | 910 | ||
| Available form | 910 | ||
| Action | 910 | ||
| Use | 910 | ||
| Diuretics | 923 | ||
| General Nursing points/Cautions for diuretics | 923 | ||
| General Patient teaching and advice for diuretics | 924 | ||
| Carbonic Anhydrase Inhibitors | 925 | ||
| ACETAZOLAMIDE (Diamox, Glaumax Powder for Injection) | 925 | ||
| Available forms | 925 | ||
| Action | 925 | ||
| Use | 925 | ||
| Dose | 925 | ||
| Adverse effects | 925 | ||
| Interactions | 925 | ||
| Nursing points/Cautions | 926 | ||
| Patient teaching and advice | 926 | ||
| High-Ceiling (Loop) Diuretics | 926 | ||
| General Actions of high-ceiling (loop) diuretics | 926 | ||
| General Uses of high-ceiling (loop) diuretics | 926 | ||
| General Adverse effects of high-ceiling (loop) diuretics | 927 | ||
| General Interactions of high-ceiling (loop) diuretics | 927 | ||
| General Nursing points/Cautions for high-ceiling (loop) diuretics | 927 | ||
| General Patient teaching and advice for high-ceiling (loop) diuretics | 928 | ||
| BUMETANIDE (Burinex) | 928 | ||
| Available form | 928 | ||
| Action | 928 | ||
| Use | 928 | ||
| Dose | 928 | ||
| Drug dependence | 945 | ||
| ACAMPROSATE CALCIUM (Campral) | 945 | ||
| Available form | 945 | ||
| Action | 945 | ||
| Use | 945 | ||
| Dose | 945 | ||
| Adverse effects | 945 | ||
| Interactions | 946 | ||
| Nursing points/Cautions | 946 | ||
| Patient teaching and advice | 946 | ||
| BUPRENORPHINE (Norspan Transdermal Patch, Subutex, Temgesic) | 946 | ||
| Available forms | 946 | ||
| Erectile dysfunction agents | 958 | ||
| Intracavernosal Administration | 959 | ||
| General Adverse effects of intracavernosal administration | 959 | ||
| General Interactions of intracavernosal administration | 959 | ||
| General Nursing points/Cautions for intracavernosal administration | 959 | ||
| General Patient teaching and advice for intracavernosal administration | 959 | ||
| ALPROSTADIL (prostaglandin E1) (Caverject, Caverject Impulse, Prostin VR) | 960 | ||
| Available forms | 960 | ||
| Action | 960 | ||
| Use | 960 | ||
| Dose | 960 | ||
| Adverse effects/interaction | 960 | ||
| Nursing points/Cautions | 960 | ||
| Patient teaching and advice | 960 | ||
| Note | 960 | ||
| PAPAVERINE HYDROCHLORIDE (DBL Papaverine Hydrochloride Injection) | 961 | ||
| Available forms | 961 | ||
| Action | 961 | ||
| Use | 961 | ||
| Dose | 961 | ||
| Adverse effects | 961 | ||
| Interactions | 961 | ||
| Nursing points and Cautions | 961 | ||
| Patient teaching and advice | 961 | ||
| Phosphodiesterase type 5 (PDE5) inhibitors | 962 | ||
| General Actions of PDE5 inhibitors | 962 | ||
| General Adverse effects of PDE5 inhibitors | 962 | ||
| General Interactions of PDE5 inhibitors | 962 | ||
| General Nursing points/Cautions for PDE5 inhibitors | 962 | ||
| General Patient teaching and advice for PDE5 inhibitors | 963 | ||
| SILDENAFIL (Revatio, Silaran, Vasafil, Vedafil, Viagra) | 963 | ||
| Available forms | 963 | ||
| Action | 963 | ||
| Use | 963 | ||
| Dose | 963 | ||
| Adverse effects | 964 | ||
| Interactions | 964 | ||
| Nursing points/Cautions | 964 | ||
| Patient teaching and advice | 964 | ||
| TADALAFIL (Adcirca, Cialis) | 964 | ||
| Available forms | 964 | ||
| Action | 964 | ||
| Use | 964 | ||
| Dose | 964 | ||
| Adverse effects | 965 | ||
| Interactions | 965 | ||
| Eye, ear, nose and throat agents | 969 | ||
| The Eye | 969 | ||
| General Nursing points/Cautions for eye preparations | 969 | ||
| Instillation of eye drops | 969 | ||
| Insertion of eye ointment | 970 | ||
| General Patient teaching and advice for eye preparations | 970 | ||
| Cycloplegic and Mydriatic Drops | 971 | ||
| General Actions of cycloplegic and mydriatic drops | 971 | ||
| General Adverse effects of cycloplegic and mydriatic drops | 971 | ||
| General Interactions of cycloplegic and mydriatic drops | 972 | ||
| General Nursing points/Cautions for cycloplegic and mydriatic drops | 972 | ||
| General Patient teaching and advice for cycloplegic and mydriatic drops | 972 | ||
| ATROPINE SULFATE MONOHYDRATE (ATROPINE SULFATE) (Atropt, Minims Atropine Eye Drops) | 972 | ||
| Available form | 972 | ||
| Action | 972 | ||
| Use | 972 | ||
| Fibrinolytic agents | 993 | ||
| General Adverse effects of fibrinolytic agents | 993 | ||
| General Interactions of fibrinolytic agents | 993 | ||
| General Nursing points/Cautions for fibrinolytic agents | 993 | ||
| ALTEPLASE (Actilyse) | 995 | ||
| Available forms | 995 | ||
| Action | 995 | ||
| Use | 995 | ||
| Dose | 995 | ||
| Adverse effects | 995 | ||
| Interactions | 995 | ||
| Nursing points/Cautions | 995 | ||
| PROTEIN C (Ceprotin) | 996 | ||
| Available form | 996 | ||
| Action | 996 | ||
| Use | 996 | ||
| Dose | 997 | ||
| Adverse effects | 997 | ||
| Interactions | 997 | ||
| Nursing points/Cautions | 997 | ||
| Patient teaching and advice | 997 | ||
| RETEPLASE (Rapilysin) | 998 | ||
| Available form | 998 | ||
| Gastrointestinal agents (miscellaneous) | 1000 | ||
| MEBEVERINE HYDROCHLORIDE (Colese, Colofac) | 1000 | ||
| Available form | 1000 | ||
| Action | 1000 | ||
| Use | 1000 | ||
| Dose | 1000 | ||
| Adverse effects | 1000 | ||
| Nursing points/Cautions | 1000 | ||
| Patient teaching and advice | 1000 | ||
| URSODEOXYCHOLIC ACID (Urso, Ursodox GH, Ursofalk, Ursosan) | 1001 | ||
| Available forms | 1001 | ||
| Action | 1001 | ||
| Use | 1001 | ||
| Dose | 1001 | ||
| Adverse effects | 1001 | ||
| Interactions | 1001 | ||
| Nursing points/Cautions | 1001 | ||
| Patient teaching and advice | 1001 | ||
| Agents Used in Inflammatory Bowel Disease | 1002 | ||
| BALSALAZIDE SODIUM (Colazide) | 1002 | ||
| Available form | 1002 | ||
| Action | 1002 | ||
| Use | 1002 | ||
| Dose | 1002 | ||
| Adverse effects | 1002 | ||
| Interactions | 1002 | ||
| Nursing points/Cautions | 1002 | ||
| Patient teaching and advice | 1002 | ||
| MESALAZINE (Mesasal, Mezavant, Pentasa, Pentasa Oral, Salofalk preparations) | 1003 | ||
| Available forms | 1003 | ||
| Action | 1003 | ||
| Use | 1003 | ||
| Dose | 1003 | ||
| Adverse effects | 1003 | ||
| Interactions | 1003 | ||
| Nursing points/Cautions | 1004 | ||
| Patient teaching and advice | 1004 | ||
| OLSALAZINE SODIUM (Dipentum) | 1005 | ||
| Available forms | 1005 | ||
| Action | 1005 | ||
| Use | 1005 | ||
| Dose | 1005 | ||
| Adverse effects | 1005 | ||
| Interactions | 1005 | ||
| General anaesthetics | 1010 | ||
| Dose | 1011 | ||
| General Adverse effects of general anaesthetics | 1011 | ||
| General Interactions of general anaesthetics | 1011 | ||
| General Nursing points/Cautions for general anaesthetics | 1011 | ||
| General Patient teaching and advice for General anaesthetics | 1012 | ||
| DESFLURANE (Suprane) | 1012 | ||
| Available form | 1012 | ||
| Properties and actions | 1012 | ||
| Use | 1012 | ||
| Adverse effects | 1012 | ||
| Interactions | 1012 | ||
| Haemopoietic agents | 1020 | ||
| General Actions of haemopoietic agents | 1020 | ||
| General Adverse effects of haemopoietic agents | 1020 | ||
| General Nursing points/Cautions for haemopoietic agents | 1021 | ||
| General Patient teaching and advice for haemopoietic agents | 1022 | ||
| DARBEPOETIN ALFA (Aranesp) | 1023 | ||
| Available forms | 1023 | ||
| Action | 1023 | ||
| Use | 1023 | ||
| Dose | 1023 | ||
| Adverse effects | 1024 | ||
| Nursing points/Cautions | 1024 | ||
| Patient teaching and advice | 1024 | ||
| EPOETIN ALFA (Eprex) | 1024 | ||
| Available forms | 1024 | ||
| Action | 1024 | ||
| Use | 1024 | ||
| Dose | 1024 | ||
| Adverse effects | 1025 | ||
| Interactions | 1025 | ||
| Nursing points/Cautions | 1025 | ||
| Patient teaching and advice | 1025 | ||
| EPOETIN BETA (NeoRecormon) | 1025 | ||
| Available forms | 1025 | ||
| Action | 1025 | ||
| Use | 1025 | ||
| Dose | 1026 | ||
| Adverse effects | 1026 | ||
| Nursing points/Cautions | 1026 | ||
| Patient teaching and advice | 1026 | ||
| EPOETIN LAMBDA (Novicrit) | 1027 | ||
| Available forms | 1027 | ||
| Action | 1027 | ||
| Use | 1027 | ||
| Dose | 1027 | ||
| Adverse effects | 1027 | ||
| Interactions | 1027 | ||
| Nursing points/Cautions | 1027 | ||
| Haemostatics | 1029 | ||
| ELTROMBOPAG OLAMINE (Revolade) | 1029 | ||
| Available forms | 1029 | ||
| Action | 1029 | ||
| Use | 1030 | ||
| Dose | 1030 | ||
| Adverse effects | 1030 | ||
| Interactions | 1030 | ||
| Nursing points/Cautions | 1030 | ||
| Patient teaching and advice | 1031 | ||
| FIBRINOGEN (RiaSTAP) | 1031 | ||
| Available form | 1031 | ||
| Action | 1031 | ||
| Use | 1031 | ||
| Dose | 1031 | ||
| Adverse effects | 1031 | ||
| Nursing points/Cautions | 1031 | ||
| Note | 1032 | ||
| ORNIPRESSIN (Por-8 Ferring) | 1032 | ||
| Available form | 1032 | ||
| Hypothalamic and pituitary hormones | 1045 | ||
| Gonadotrophin-Releasing Hormone | 1046 | ||
| GOSERELIN ACETATE (Zoladex 3.6 mg Implant, Zoladex 10.8 mg Implant) | 1046 | ||
| Available forms | 1046 | ||
| Action | 1046 | ||
| Use | 1046 | ||
| Dose | 1046 | ||
| Adverse effects | 1047 | ||
| Interactions | 1047 | ||
| Nursing points/Cautions | 1047 | ||
| Patient teaching and advice | 1048 | ||
| Note | 1048 | ||
| LEUPRORELIN ACETATE (Eligard, Lucrin, Lucrin Depot) | 1048 | ||
| Available forms | 1048 | ||
| Action | 1048 | ||
| Use | 1048 | ||
| Dose | 1048 | ||
| Adverse effects | 1048 | ||
| Interactions | 1049 | ||
| Nursing points/Cautions | 1049 | ||
| Patient teaching and advice | 1049 | ||
| Growth Hormone Release-Inhibiting Factor | 1050 | ||
| LANREOTIDE ACETATE (Somatuline Autogel, Somatuline LA) | 1050 | ||
| Available forms | 1050 | ||
| Action | 1050 | ||
| Use | 1050 | ||
| Dose | 1050 | ||
| Acromegaly | 1050 | ||
| Carcinoid tumour | 1050 | ||
| GEP endocrine tumours | 1050 | ||
| Adverse effects | 1050 | ||
| Interactions | 1050 | ||
| Nursing points/Cautions | 1051 | ||
| Patient teaching and advice | 1051 | ||
| OCTREOTIDE (DBL Octreotide Injection, Octreotide MaxRx, Octreotide Sun, Sandostatin, Sandostatin LAR) | 1051 | ||
| Available forms | 1051 | ||
| Action | 1051 | ||
| Use | 1051 | ||
| Dose | 1051 | ||
| Acromegaly | 1051 | ||
| GEP endocrine tumour | 1052 | ||
| Complications after pancreatic surgery | 1052 | ||
| Advanced neuroendocrine tumour of midgut | 1052 | ||
| Adverse effects | 1052 | ||
| Interactions | 1052 | ||
| Nursing points/Cautions | 1052 | ||
| Patient teaching and advice | 1053 | ||
| PASIREOTIDE (Signifor, Signifor LAR) | 1053 | ||
| Available form | 1053 | ||
| Action | 1053 | ||
| Use | 1053 | ||
| Dose | 1054 | ||
| Adverse effects | 1054 | ||
| Interactions | 1054 | ||
| Nursing points/Cautions | 1054 | ||
| Patient teaching and advice | 1055 | ||
| Anterior Pituitary Hormones | 1056 | ||
| Growth Hormone (Somatotropic Hormones) | 1056 | ||
| SOMATROPIN (SOMATOTROPHIN/SOMATOTROPIN) (Genotropin, Genotropin GoQuick, Genotropin MiniQuick, Humatrope, Norditropin, NutropinAq Cartridge Solution for Injection, Omnitrope, Saizen, SciTropin A, Zomacton) | 1056 | ||
| Available forms | 1056 | ||
| Action | 1056 | ||
| Use | 1056 | ||
| Dose | 1056 | ||
| Adverse effects | 1057 | ||
| Interactions | 1057 | ||
| Nursing points/Cautions | 1057 | ||
| Patient teaching and advice | 1058 | ||
| TETRACOSACTIDE (TETRACOSACTRIN) (Synacthen, Synacthen Depot) | 1058 | ||
| Available forms | 1058 | ||
| Action | 1058 | ||
| Use | 1059 | ||
| Dose | 1059 | ||
| Adverse effects | 1059 | ||
| Interactions | 1059 | ||
| Nursing points/Cautions | 1059 | ||
| Patient teaching and advice | 1060 | ||
| Prolactin Suppression | 1061 | ||
| QUINAGOLIDE HYDROCHLORIDE (Norprolac) | 1061 | ||
| Available forms | 1061 | ||
| Action | 1061 | ||
| Use | 1061 | ||
| Dose | 1061 | ||
| Adverse effects | 1061 | ||
| Interactions | 1061 | ||
| Nursing points/Cautions | 1061 | ||
| Patient teaching and advice | 1061 | ||
| Posterior Pituitary Hormones | 1062 | ||
| Antidiuretic Hormone (ADH) | 1062 | ||
| DESMOPRESSIN (Minirin Melt, Minirin Tablets) DESMOPRESSIN ACETATE (Minirin Injection, Minirin Nasal Spray or Solution, Octostim Injection) | 1062 | ||
| Available forms | 1062 | ||
| Action | 1062 | ||
| Use | 1062 | ||
| Dose | 1062 | ||
| Adverse effects | 1063 | ||
| Interactions | 1063 | ||
| Nursing points/Cautions | 1063 | ||
| Patient teaching and advice | 1064 | ||
| TERLIPRESSIN (Glypressin Solution, Lucassin) | 1065 | ||
| Available form | 1065 | ||
| Action | 1065 | ||
| Use | 1065 | ||
| Dose | 1065 | ||
| Adverse effects | 1065 | ||
| Interactions | 1065 | ||
| Nursing points/Cautions | 1065 | ||
| VASOPRESSIN (Pitressin) | 1066 | ||
| Available form | 1066 | ||
| Action | 1066 | ||
| Use | 1066 | ||
| Dose | 1066 | ||
| Adverse effects | 1066 | ||
| Interactions | 1066 | ||
| Nursing points/Cautions | 1066 | ||
| Patient teaching and advice | 1067 | ||
| Immunomodifiers | 1068 | ||
| General Adverse effects of immunomodifiers | 1068 | ||
| General Interactions of immunomodifiers | 1068 | ||
| General Nursing points/Cautions for immunomodifiers | 1068 | ||
| General Patient teaching and advice for immunomodifiers | 1069 | ||
| ANTITHYMOCYTE GLOBULIN | 1069 | ||
| ANTITHYMOCYTE GLOBULIN (RABBIT) (Thymoglobuline) | 1069 | ||
| Available form | 1069 | ||
| Action | 1069 | ||
| Use | 1069 | ||
| Dose | 1069 | ||
| Adverse effects | 1070 | ||
| Interactions | 1070 | ||
| Nursing points/Cautions | 1070 | ||
| Patient teaching and advice | 1071 | ||
| APREMILAST (Otezla) | 1071 | ||
| Available form | 1071 | ||
| Action | 1071 | ||
| Use | 1071 | ||
| Dose | 1071 | ||
| Adverse effects | 1071 | ||
| Interactions | 1071 | ||
| Nursing points/Cautions | 1071 | ||
| Patient teaching and advice | 1072 | ||
| AZATHIOPRINE (Azamun, Azapin, Azran, Imazan, Imuran, Thioprine) | 1072 | ||
| Available forms | 1072 | ||
| Action | 1072 | ||
| Use | 1072 | ||
| Dose | 1072 | ||
| Adverse effects | 1072 | ||
| Interactions | 1072 | ||
| Nursing points/Cautions | 1073 | ||
| Patient teaching and advice | 1073 | ||
| BASILIXIMAB (Simulect) | 1073 | ||
| Available form | 1073 | ||
| Laxatives | 1108 | ||
| General Uses of laxatives | 1108 | ||
| General Adverse effects of laxatives | 1108 | ||
| General Nursing points/Cautions for laxatives | 1109 | ||
| General Patient teaching and advice for laxatives | 1109 | ||
| Bulk-Forming Laxatives | 1110 | ||
| General Actions of bulk-forming laxatives | 1110 | ||
| ISPAGHULA (Fybogel) | 1110 | ||
| Lipid regulating agents | 1122 | ||
| HMG-CoA Reductase Inhibitors (Statins) | 1123 | ||
| General Actions of statins | 1123 | ||
| General Uses of statins | 1124 | ||
| General Adverse effects of statins | 1124 | ||
| General Interactions of statins | 1124 | ||
| General Nursing points/Cautions for statins | 1124 | ||
| General Patient teaching and advice for statins | 1125 | ||
| ATORVASTATIN (Atorvachol, Lipitor, Lorstat, Torvastat, Trovas) | 1125 | ||
| Available forms | 1125 | ||
| Action | 1126 | ||
| Use | 1126 | ||
| Local anaesthetics | 1139 | ||
| General Actions of local anaesthetics | 1139 | ||
| Surface (topical) anaesthesia | 1139 | ||
| Local (infiltration) anaesthesia | 1139 | ||
| Regional nerve block anaesthesia | 1139 | ||
| Spinal anaesthesia | 1139 | ||
| General Uses of local anaesthetics | 1140 | ||
| General Doses for local anaesthetics | 1140 | ||
| General Adverse effects of local anaesthetics | 1140 | ||
| General Interactions of local anaesthetics | 1140 | ||
| General Nursing points/Cautions for local anaesthetics | 1140 | ||
| General Patient teaching and advice for local anaesthetics | 1142 | ||
| ARTICAINE HYDROCHLORIDE | 1142 | ||
| Metabolic disorders agents | 1151 | ||
| AGALSIDASE ALFA (GHU) (Replagal) | 1151 | ||
| Available form | 1151 | ||
| Action | 1151 | ||
| Use | 1151 | ||
| Dose | 1151 | ||
| Adverse effects | 1151 | ||
| Interactions | 1152 | ||
| Nursing points/Cautions | 1152 | ||
| Patient teaching and advice | 1152 | ||
| AGALSIDASE BETA (RCH) (Fabrazyme) | 1152 | ||
| Available forms | 1152 | ||
| Action | 1152 | ||
| Use | 1152 | ||
| Dose | 1152 | ||
| Adverse effects | 1152 | ||
| Interactions | 1153 | ||
| Nursing points/Cautions | 1153 | ||
| Patient teaching and advice | 1153 | ||
| ALGLUCOSIDASE ALFA (RHU) (Myozyme) | 1153 | ||
| Available form | 1153 | ||
| Action | 1153 | ||
| Use | 1154 | ||
| Dose | 1154 | ||
| Adverse effects | 1154 | ||
| Nursing points/Cautions | 1154 | ||
| Patient teaching and advice | 1154 | ||
| ASFOTASE ALFA (Strensiq) | 1155 | ||
| Available form | 1155 | ||
| Action | 1155 | ||
| Use | 1155 | ||
| Dose | 1155 | ||
| Adverse effects | 1155 | ||
| Interaction | 1155 | ||
| Nursing points/Cautions | 1155 | ||
| Movement disorder agents | 1169 | ||
| Multiple Sclerosis | 1169 | ||
| ALEMTUZUMAB (Lemtrada, MabCampath) | 1170 | ||
| Available form | 1170 | ||
| Action | 1170 | ||
| Use | 1170 | ||
| Dose | 1170 | ||
| Adverse effects | 1170 | ||
| Interactions | 1170 | ||
| Nursing points/Cautions | 1170 | ||
| Patient teaching and advice | 1171 | ||
| DIMETHYL FUMARATE (Tecfidera) | 1171 | ||
| Available form | 1171 | ||
| Action | 1171 | ||
| Use | 1171 | ||
| Muscle relaxants | 1187 | ||
| BACLOFEN (Bacthecal, Clofen, Lioresal, Lioresal Intrathecal, Stelax) | 1187 | ||
| Available forms | 1187 | ||
| Action | 1187 | ||
| Use | 1187 | ||
| Dose | 1187 | ||
| Adverse effects | 1188 | ||
| Interactions | 1188 | ||
| Nursing points/Cautions | 1188 | ||
| Patient teaching and advice | 1190 | ||
| BOTULINUM TOXIN TYPE A (Botox, Dysport) | 1190 | ||
| Available forms | 1190 | ||
| Action | 1190 | ||
| Use | 1190 | ||
| Dose | 1191 | ||
| Adverse effects | 1191 | ||
| General | 1191 | ||
| Blepharospasm | 1191 | ||
| Strabismus | 1191 | ||
| Spasmodic dysphonia | 1191 | ||
| Cervical dystonia (spasmodic torticollis) | 1191 | ||
| Nerve VII disorder | 1191 | ||
| Focal spasticity (upper limb, post-stroke) | 1191 | ||
| Hyperhidrosis | 1191 | ||
| Focal spasticity (children) | 1191 | ||
| Chronic migraine | 1191 | ||
| Overactive bladder/Neurogenic detrusor overactivity | 1191 | ||
| Glabellar lines | 1191 | ||
| Crow’s feet | 1191 | ||
| Forehead lines | 1191 | ||
| Interactions | 1191 | ||
| Nursing points/Cautions | 1192 | ||
| Patient teaching and advice | 1193 | ||
| DANTROLENE SODIUM HEMIHEPTAHYDRATE (DANTROLENE SODIUM) (Dantrium Capsules, Dantrium Powder for Injection) | 1194 | ||
| Available forms | 1194 | ||
| Action | 1194 | ||
| Use | 1194 | ||
| Dose | 1194 | ||
| Adverse effects | 1194 | ||
| Interactions | 1194 | ||
| Nursing points/Cautions | 1194 | ||
| Patient teaching and advice | 1195 | ||
| INCOBOTULINUMTOXINA (Xeomin) | 1195 | ||
| Available form | 1195 | ||
| Action | 1195 | ||
| Use | 1195 | ||
| Dose | 1195 | ||
| Adverse effects | 1196 | ||
| General | 1196 | ||
| Blepharospasm | 1196 | ||
| Cervical dystonia (spasmodic torticollis) | 1196 | ||
| Spasticity (upper limb, post-stroke) | 1196 | ||
| Glabellar lines | 1196 | ||
| Interactions | 1196 | ||
| Nursing points/Cautions | 1196 | ||
| Patient teaching and advice | 1197 | ||
| ORPHENADRINE CITRATE (Norflex) | 1197 | ||
| Available form | 1197 | ||
| Action | 1197 | ||
| Neuromuscular blocking agents | 1200 | ||
| Non-Depolarising Blocking Agents | 1200 | ||
| General Actions of non-depolarising blocking agents | 1200 | ||
| General Uses of non-depolarising blocking agents | 1200 | ||
| General Adverse effects of non-depolarising blocking agents | 1201 | ||
| General Interactions of non-depolarising blocking agents | 1201 | ||
| General Nursing points/Cautions for non-depolarising blocking agents | 1201 | ||
| General Patient teaching and advice for non-depolarising blocking agents | 1202 | ||
| ATRACURIUM BESYLATE (DBL Atracurium Besylate Injection, Tracrium Injectable) | 1203 | ||
| Opioid analgesics | 1209 | ||
| General Actions of opioids | 1210 | ||
| General Adverse effects of opioids | 1210 | ||
| General Interactions of opioids | 1210 | ||
| General Nursing points/Cautions for opioids | 1211 | ||
| General Patient teaching and advice for opioids | 1213 | ||
| ALFENTANIL HYDROCHLORIDE (Alfentanil GH, Rapifen) | 1213 | ||
| Available forms | 1213 | ||
| Action | 1213 | ||
| Use | 1213 | ||
| Dose | 1213 | ||
| Adverse effects | 1213 | ||
| Interactions | 1213 | ||
| Nursing points/Cautions | 1214 | ||
| Patient teaching and advice | 1214 | ||
| BUPRENORPHINE (Norspan Transdermal Patch, Subutex, Temgesic) | 1214 | ||
| Available forms | 1214 | ||
| Action | 1214 | ||
| Use | 1214 | ||
| Dose | 1214 | ||
| Adverse effects | 1214 | ||
| Interactions | 1215 | ||
| Nursing points/Cautions | 1215 | ||
| Patient teaching and advice | 1215 | ||
| Note | 1216 | ||
| CODEINE PHOSPHATE HEMIHYDRATE (CODEINE PHOSPHATE) (Actacode Linctus, Codeine Linctus, Codeine Phosphate Tablets) | 1216 | ||
| Available forms | 1216 | ||
| Action | 1216 | ||
| Pregnancy, childbirth and breastfeeding | 1233 | ||
| Agents Used to Treat Infertility | 1233 | ||
| General Adverse effects of infertility agents | 1234 | ||
| General Nursing points/Cautions for infertility agents | 1235 | ||
| General Patient teaching and advice for infertility agents | 1235 | ||
| CETRORELIX ACETATE (Cetrotide) | 1235 | ||
| Available forms | 1235 | ||
| Pulmonary hypertension agents | 1266 | ||
| AMBRISENTAN (Volibris) | 1266 | ||
| Available forms | 1266 | ||
| Action | 1266 | ||
| Use | 1266 | ||
| Dose | 1266 | ||
| Adverse effects | 1266 | ||
| Interactions | 1267 | ||
| Nursing points/Cautions | 1267 | ||
| Patient teaching and advice | 1267 | ||
| BOSENTAN MONOHYDRATE (Tracleer) | 1267 | ||
| Available forms | 1267 | ||
| Action | 1267 | ||
| Use | 1267 | ||
| Dose | 1268 | ||
| Adverse effects | 1268 | ||
| Interactions | 1268 | ||
| Nursing points/Cautions | 1268 | ||
| Patient teaching and advice | 1268 | ||
| EPOPROSTENOL (Flolan, Veletri) | 1269 | ||
| Available forms | 1269 | ||
| Action | 1269 | ||
| Use | 1269 | ||
| Dose | 1269 | ||
| Adverse effects | 1269 | ||
| Interactions | 1269 | ||
| Nursing points/Cautions | 1269 | ||
| Patient teaching and advice | 1270 | ||
| ILOPROST TROMETAMOL (Ventavis) | 1270 | ||
| Available form | 1270 | ||
| Action | 1270 | ||
| Use | 1270 | ||
| Dose | 1270 | ||
| Adverse effects | 1271 | ||
| Interactions | 1271 | ||
| Nursing points/Cautions | 1271 | ||
| Patient teaching and advice | 1271 | ||
| MACITENTAN (Opsumit) | 1271 | ||
| Available form | 1271 | ||
| Action | 1272 | ||
| Use | 1272 | ||
| Dose | 1272 | ||
| Adverse effects | 1272 | ||
| Interactions | 1272 | ||
| Nursing points/Cautions | 1272 | ||
| Patient teaching and advice | 1272 | ||
| SELEXIPAG (Uptravi) | 1273 | ||
| Available form | 1273 | ||
| Action | 1273 | ||
| Use | 1273 | ||
| Dose | 1273 | ||
| Adverse effects | 1273 | ||
| Interactions | 1273 | ||
| Nursing points/Cautions | 1273 | ||
| Patient teaching and advice | 1274 | ||
| TREPROSTINIL SODIUM (Remodulin) | 1274 | ||
| Available forms | 1274 | ||
| Action | 1274 | ||
| Use | 1274 | ||
| Dose | 1274 | ||
| Adverse effects | 1274 | ||
| Interactions | 1274 | ||
| Nursing points/Cautions | 1275 | ||
| Patient teaching and advice | 1275 | ||
| Sedatives and hypnotics | 1276 | ||
| General Adverse effects of sedatives and hypnotics | 1277 | ||
| General Interactions of sedatives and hypnotics | 1277 | ||
| General Nursing points/Cautions for sedatives and hypnotics | 1277 | ||
| General Patient teaching and advice for sedatives and hypnotics | 1278 | ||
| CHLORAL HYDRATE (Chloral Hydrate Mixture) | 1279 | ||
| Available form | 1279 | ||
| Action | 1279 | ||
| Use | 1279 | ||
| Dose | 1279 | ||
| Adverse effects | 1279 | ||
| Interactions | 1279 | ||
| Nursing points/Cautions | 1279 | ||
| Patient teaching and advice | 1280 | ||
| DEXMEDETOMIDINE (Precedex) | 1280 | ||
| Available form | 1280 | ||
| Action | 1280 | ||
| Use | 1280 | ||
| Dose | 1280 | ||
| Adverse effects | 1280 | ||
| Interactions | 1280 | ||
| Nursing points/Cautions | 1280 | ||
| FLUNITRAZEPAM (Hypnodorm) | 1281 | ||
| Sex hormones | 1288 | ||
| Androgens and Anabolic Steroids | 1288 | ||
| General Actions of androgens and anabolic steroids | 1288 | ||
| General Uses of androgens and anabolic steroids | 1289 | ||
| General Adverse effects of androgens and anabolic steroids | 1289 | ||
| General Interactions of androgens and anabolic steroids | 1289 | ||
| General Nursing points/Cautions for androgens and anabolic steroids | 1289 | ||
| General Patient teaching and advice for androgens and anabolic steroids | 1290 | ||
| MESTEROLONE (Proviron) | 1291 | ||
| Stimulants | 1325 | ||
| General Adverse effects of stimulants | 1325 | ||
| General Nursing points/Cautions for stimulants | 1326 | ||
| General Patient teaching and advice for stimulants | 1326 | ||
| ARMODAFINIL (Nuvigil) | 1327 | ||
| Available form | 1327 | ||
| Action | 1327 | ||
| Use | 1327 | ||
| Dose | 1327 | ||
| Adverse effects | 1327 | ||
| Interactions | 1327 | ||
| Nursing points/Cautions | 1327 | ||
| Patient teaching and advice | 1328 | ||
| ATOMOXETINE (Strattera) | 1328 | ||
| Available forms | 1328 | ||
| Action | 1328 | ||
| Use | 1328 | ||
| Dose | 1328 | ||
| Adverse effects | 1328 | ||
| Interactions | 1328 | ||
| Nursing points/Cautions | 1329 | ||
| Patient teaching and advice | 1329 | ||
| CAFFEINE (No Doz) | 1329 | ||
| Sympathomimetic agents | 1335 | ||
| General Interactions of sympathomimetic agents | 1335 | ||
| General Nursing points/Cautions for sympathomimetic agents | 1336 | ||
| ADRENALINE (EPINEPHRINE) (Epipen, Epipen Jr) ADRENALINE (EPINEPHRINE) ACID TARTRATE (Adrenaline–Link Injection BP, Aspen Adrenaline Injection) ADRENALINE (EPINEPHRINE) HYDROCHLORIDE (Adrenaline Hydrochloride Injection 1 : 10,000 (Min-I-Jet)) | 1336 | ||
| Available forms | 1336 | ||
| Action | 1337 | ||
| Use | 1337 | ||
| Dose | 1337 | ||
| Anaphylaxis | 1337 | ||
| Cardiopulmonary resuscitation (in absence of ventricular fibrillation) | 1337 | ||
| Adverse effects | 1337 | ||
| Interactions | 1338 | ||
| Nursing points/Cautions | 1338 | ||
| Patient teaching and advice | 1338 | ||
| Note | 1339 | ||
| DOBUTAMINE HYDROCHLORIDE (DBL Dobutamine Hydrochloride Injection, Dobutrex) | 1339 | ||
| Available forms | 1339 | ||
| Action | 1339 | ||
| Use | 1339 | ||
| Dose | 1339 | ||
| Adverse effects | 1339 | ||
| Interactions | 1339 | ||
| Nursing points/Cautions | 1340 | ||
| DOPAMINE HYDROCHLORIDE (DBL Sterile Dopamine Concentrate) | 1340 | ||
| Available form | 1340 | ||
| Action | 1340 | ||
| Use | 1340 | ||
| Dose | 1341 | ||
| Adverse effects | 1341 | ||
| Interactions | 1341 | ||
| Nursing points/Cautions | 1341 | ||
| EPHEDRINE SULFATE (DBL Ephedrine Sulfate Injection) | 1342 | ||
| Available form | 1342 | ||
| Action | 1342 | ||
| Use | 1342 | ||
| Dose | 1342 | ||
| Adverse effects | 1342 | ||
| Interactions | 1342 | ||
| Nursing points/Cautions | 1342 | ||
| Note | 1343 | ||
| ISOPRENALINE HYDROCHLORIDE (known as isoproterenol in USA) (Isuprel) | 1343 | ||
| Available forms | 1343 | ||
| Action | 1343 | ||
| Use | 1343 | ||
| Dose | 1343 | ||
| Adverse effects | 1344 | ||
| Interactions | 1344 | ||
| Nursing points/Cautions | 1344 | ||
| METARAMINOL TARTRATE (Metaraminol Montrose) | 1344 | ||
| Available form | 1344 | ||
| Action | 1344 | ||
| Use | 1344 | ||
| Thyroid and antithyroid agents | 1348 | ||
| Thyroid Agents | 1350 | ||
| LIOTHYRONINE SODIUM (Tertroxin) | 1350 | ||
| Available form | 1350 | ||
| Action | 1350 | ||
| Use | 1350 | ||
| Dose | 1350 | ||
| Adverse effects | 1350 | ||
| Interactions | 1350 | ||
| Nursing points/Cautions | 1350 | ||
| Patient teaching and advice | 1351 | ||
| THYROXINE SODIUM (Eltroxin, Eutroxsig, Oroxine) | 1351 | ||
| Available forms | 1351 | ||
| Action | 1351 | ||
| Use | 1351 | ||
| Dose | 1351 | ||
| Adverse effects | 1351 | ||
| Interactions | 1351 | ||
| Nursing points/Cautions | 1352 | ||
| Patient teaching and advice | 1352 | ||
| Antithyroid Agents | 1353 | ||
| CARBIMAZOLE (Carbimazol Aristo, Neo-Mercazole) | 1353 | ||
| Available form | 1353 | ||
| Action | 1353 | ||
| Use | 1353 | ||
| Dose | 1353 | ||
| Adverse effects | 1354 | ||
| Interactions | 1354 | ||
| Nursing points/Cautions | 1354 | ||
| Patient teaching and advice | 1354 | ||
| PROPYLTHIOURACIL (PTU) | 1354 | ||
| Available form | 1354 | ||
| Action | 1354 | ||
| Use | 1355 | ||
| Dose | 1355 | ||
| Adverse effects | 1355 | ||
| Interactions | 1355 | ||
| Nursing points/Cautions | 1355 | ||
| Patient teaching and advice | 1355 | ||
| SODIUM IODIDE (131I) (Sodium Iodide (131I) Capsules (Therapy), (Sodium Iodide (131I) Solution BP (Therapy) | 1356 | ||
| Available forms | 1356 | ||
| Action | 1356 | ||
| Use | 1356 | ||
| Dose | 1356 | ||
| Adverse effects | 1356 | ||
| Interactions | 1356 | ||
| Nursing points/Cautions | 1356 | ||
| Patient teaching and advice | 1357 | ||
| Vaccines, immunoglobulins and antivenoms | 1358 | ||
| Vaccines | 1358 | ||
| General Actions of vaccines | 1358 | ||
| General Uses of vaccines | 1358 | ||
| General Interactions of vaccines | 1358 | ||
| General Nursing points/Cautions for vaccines | 1359 | ||
| General Patient teaching and advice for vaccines | 1361 | ||
| Notes | 1362 | ||
| Overseas travel and vaccination | 1362 | ||
| Healthcare workers and vaccination | 1362 | ||
| BCG VACCINE (BCG Vaccine) | 1364 | ||
| Vasodilators | 1400 | ||
| ALPROSTADIL (prostaglandin E1) (Caverject, Caverject Impulse, Prostin VR) | 1400 | ||
| Available forms | 1400 | ||
| Action | 1400 | ||
| Use | 1400 | ||
| Dose | 1400 | ||
| Adverse effects | 1400 | ||
| Nursing points/Cautions | 1400 | ||
| BETAHISTINE DIHYDROCHLORIDE (Seniere, Serc) | 1401 | ||
| Vitamins, minerals and electrolytes | 1403 | ||
| Vitamins | 1403 | ||
| Vitamin A | 1403 | ||
| VITAMIN A (also known as Retinol) (Blackmores Vitamin A 5000, Nature’s Own Vitamin A 5000 IU, Phebra Vitamin A 50,000 IU) | 1403 | ||
| Available forms | 1403 | ||
| Action | 1403 | ||
| Miscellaneous agents | 1437 | ||
| EICOSAPENTAENOIC ACID/DOCOSAHEXAENOIC ACID (Omacor) | 1437 | ||
| Available form | 1437 | ||
| Action | 1437 | ||
| Use | 1437 | ||
| Dose | 1437 | ||
| Adverse effects | 1437 | ||
| Interactions | 1437 | ||
| Appendix 1: Poisoning and its treatment | 1447 | ||
| Aims | 1448 | ||
| Action | 1448 | ||
| Swallowed poison | 1448 | ||
| Inhaled poison | 1448 | ||
| Poison in contact with skin | 1449 | ||
| Poison in contact with eyes | 1449 | ||
| Hospital management | 1449 | ||
| Treatment with activated charcoal (Carbosorb X) | 1450 | ||
| Action and use | 1450 | ||
| Adult dose | 1450 | ||
| Paediatric dose | 1451 | ||
| Nursing points/Cautions | 1451 | ||
| Note | 1451 | ||
| Appendix 2: Poisons information centres and medicine information centres | 1452 | ||
| Poisons information centres | 1452 | ||
| Appendix 3: Changes to drug names | 1454 | ||
| Appendix 4: Normal Reference Values | 1456 | ||
| Reference intervals for haematology | 1456 | ||
| Reference intervals* for clinical chemistry (blood, serum and plasma) | 1458 | ||
| Reference intervals for therapeutic drug monitoring (serum) | 1462 | ||
| Reference intervals* for clinical chemistry (urine) | 1465 | ||
| Reference intervals for toxic substances | 1467 | ||
| Reference intervals for tests performed on cerebrospinal fluid (CSF) | 1468 | ||
| Reference intervals for tests of gastrointestinal function | 1468 | ||
| Reference intervals for tests of immunological function | 1469 | ||
| Lymphocyte subsets, whole blood, heparinised | 1469 | ||
| Reference values for semen analysis | 1470 | ||
| Bibliography | 1471 | ||
| Glossary | 1481 | ||
| Drug administration | 1485 | ||
| Topical applications | 1486 | ||
| Index | 1487 | ||
| A | 1487 | ||
| B | 1496 | ||
| C | 1500 | ||
| D | 1506 | ||
| E | 1511 | ||
| F | 1513 | ||
| G | 1516 | ||
| H | 1518 | ||
| I | 1522 | ||
| J | 1525 | ||
| K | 1525 | ||
| L | 1525 | ||
| M | 1529 | ||
| N | 1534 | ||
| O | 1537 | ||
| P | 1539 | ||
| Q | 1546 | ||
| R | 1546 | ||
| S | 1548 | ||
| T | 1553 | ||
| U | 1557 | ||
| V | 1558 | ||
| W | 1560 | ||
| X | 1560 | ||
| Y | 1560 | ||
| Z | 1560 | ||
| Havard’s nursing guide to drugs 10e | 1563 | ||
| Common Abbreviations | 1563 | ||
| Times | 1563 | ||
| Routes | 1563 | ||
| Useful units and concentrations | 1563 | ||
| Drug Doses and Drip Rates Calculation Formulae | 1564 | ||
| Oral drugs (solids, liquids) | 1564 | ||
| Parenteral drugs | 1564 | ||
| Solutions (IM, IV injections) | 1564 | ||
| Powders | 1564 | ||
| IV infusions | 1564 | ||
| Infusion pumps | 1564 | ||
| Inside Back Cover | ibc1 |